Furthermore, in vivo data showed that ornidazole treatment dramatically reduced tumor volume, specifically targeted CD133+ CSCs, upregulated pathways associated with cellular and ER-related stress, inhibited the Shh signaling and ER-stress mediated autophagy process, and activated two different apoptosis pathways in melanoma tumors. The gene discussed is PROM1; the disease is melanoma.